These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 8117420)

  • 1. The effects of novel cholinesterase inhibitors and selective muscarinic receptor agonists in tests of reference and working memory.
    Dawson GR; Iversen SD
    Behav Brain Res; 1993 Nov; 57(2):143-53. PubMed ID: 8117420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of the effects of the novel muscarinic receptor agonists L-689,660 and AF102B in tests of reference and working memory.
    Dawson GR; Bayley P; Channell S; Iversen SD
    Psychopharmacology (Berl); 1994 Jan; 113(3-4):361-8. PubMed ID: 7862846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. (+-)-cis-2-methyl-spiro(1,3-oxathiolane-5,3')quinuclidine, an M1 selective cholinergic agonist, attenuates cognitive dysfunctions in an animal model of Alzheimer's disease.
    Fisher A; Brandeis R; Karton I; Pittel Z; Gurwitz D; Haring R; Sapir M; Levy A; Heldman E
    J Pharmacol Exp Ther; 1991 Apr; 257(1):392-403. PubMed ID: 2019998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The behavioral effects of heptyl physostigmine, a new cholinesterase inhibitor, in tests of long-term and working memory in rodents.
    Dawson GR; Bentley G; Draper F; Rycroft W; Iversen SD; Pagella PG
    Pharmacol Biochem Behav; 1991 Aug; 39(4):865-71. PubMed ID: 1763105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. L-689,660, a novel cholinomimetic with functional selectivity for M1 and M3 muscarinic receptors.
    Hargreaves RJ; McKnight AT; Scholey K; Newberry NR; Street LJ; Hutson PH; Semark JE; Harley EA; Patel S; Freedman SB
    Br J Pharmacol; 1992 Oct; 107(2):494-501. PubMed ID: 1422595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the effects of selective and nonselective muscarinic agonists on cognition and thermoregulation in primates.
    Rupniak NM; Tye SJ; Iversen SD
    J Neurol Sci; 1992 Jul; 110(1-2):222-7. PubMed ID: 1506863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Excitatory and inhibitory effects of second-generation cholinesterase inhibitors on rat gastrointestinal transit.
    Braida D; Virag W; Ottonello F; Sala M
    Pharmacol Res; 2000 Jun; 41(6):671-7. PubMed ID: 10816338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Xanomeline compared to other muscarinic agents on stimulation of phosphoinositide hydrolysis in vivo and other cholinomimetic effects.
    Bymaster FP; Carter PA; Peters SC; Zhang W; Ward JS; Mitch CH; Calligaro DO; Whitesitt CA; DeLapp N; Shannon HE; Rimvall K; Jeppesen L; Sheardown MJ; Fink-Jensen A; Sauerberg P
    Brain Res; 1998 Jun; 795(1-2):179-90. PubMed ID: 9622623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Central muscarinic activities of an M1-selective agonist: preferential effect on reversal of amnesia.
    Nakahara N; Fujise N; Kawanishi G; Mizobe F
    Brain Res; 1990 Jan; 507(1):172-5. PubMed ID: 2302575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The selective positive allosteric M1 muscarinic receptor modulator PQCA attenuates learning and memory deficits in the Tg2576 Alzheimer's disease mouse model.
    Puri V; Wang X; Vardigan JD; Kuduk SD; Uslaner JM
    Behav Brain Res; 2015; 287():96-9. PubMed ID: 25800972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions between scopolamine and muscarinic cholinergic agonists or cholinesterase inhibitors on spatial alternation performance in rats.
    Shannon HE; Bemis KG; Hendrix JC; Ward JS
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1071-7. PubMed ID: 2262893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blockade of hippocampal M1 muscarinic receptors impairs working memory performance of rats.
    Ohno M; Yamamoto T; Watanabe S
    Brain Res; 1994 Jul; 650(2):260-6. PubMed ID: 7953691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of (-)-S-2,8-dimethyl-3-methylene-1-oxa-8-azaspiro[4,5]decane L-tartrate monohydrate (YM796), a novel muscarinic agonist, on disturbance of passive avoidance learning behavior in drug-treated and senescence-accelerated mice.
    Suzuki M; Yamaguchi T; Ozawa Y; Ohyama M; Yamamoto M
    J Pharmacol Exp Ther; 1995 Nov; 275(2):728-36. PubMed ID: 7473160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory effect of orally administered donepezil hydrochloride (E2020), a novel treatment for Alzheimer's disease, on cholinesterase activity in rats.
    Kosasa T; Kuriya Y; Matsui K; Yamanishi Y
    Eur J Pharmacol; 2000 Feb; 389(2-3):173-9. PubMed ID: 10688981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of nicotinic receptors in the amelioration of cholinesterase inhibitors in scopolamine-induced memory deficits.
    Masuoka T; Kamei C
    Psychopharmacology (Berl); 2009 Oct; 206(2):259-65. PubMed ID: 19639304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progress in medicinal chemistry of novel selective muscarinic agonists.
    Fisher A; Karton Y; Heldman E; Gurwitz D; Haring R; Meshulam H; Brandeis R; Pittel Z; Segall Y; Marciano D
    Drug Des Discov; 1993; 9(3-4):221-35. PubMed ID: 8400004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of novel tacrine-related cholinesterase inhibitors in the reversal of 3-quinuclidinyl benzilate-induced cognitive deficit in rats--Is there a potential for Alzheimer's disease treatment?
    Misik J; Korabecny J; Nepovimova E; Kracmarova A; Kassa J
    Neurosci Lett; 2016 Jan; 612():261-268. PubMed ID: 26708634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Critical role of CA1 muscarinic receptors on memory acquisition deficit induced by total (TSD) and REM sleep deprivation (RSD).
    Javad-Moosavi BZ; Vaezi G; Nasehi M; Haeri-Rouhani SA; Zarrindast MR
    Prog Neuropsychopharmacol Biol Psychiatry; 2017 Oct; 79(Pt B):128-135. PubMed ID: 28571775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The dual-acting H3 receptor antagonist and AChE inhibitor UW-MD-71 dose-dependently enhances memory retrieval and reverses dizocilpine-induced memory impairment in rats.
    Khan N; Saad A; Nurulain SM; Darras FH; Decker M; Sadek B
    Behav Brain Res; 2016 Jan; 297():155-64. PubMed ID: 26467607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of galantamine and donepezil on active and passive avoidance tests in rats with induced hypoxia.
    Dimitrova DS; Getova-Spassova DP
    J Pharmacol Sci; 2006 Jul; 101(3):199-204. PubMed ID: 16861821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.